Recognition follows nomination by fellow founders and highlights the strength of Ireland’s start-up community and the growing role of cannabinoid medicines in mainstream pharmaceutical manufacturing.Athlone, Ireland — [16 October 2026] — Dunbar Pharmaceuticals...
Three members of the Dunbar Pharma team have been shortlisted for a combined four nominations at the Cannabis Industry Awards 2026, highlighting their dedication and contributions to scientific excellence, innovation and environmental sustainability within the...
Dunbar Pharma has been featured in the Business Post, highlighting the company’s continued international expansion and plans for the UK and German pharmaceutical markets.The article explores Dunbar Pharma’s growth from its manufacturing base in Athlone and the...
Irish manufacturer brings commercial-scale, EU GMP-certified production and reliable supply to medicines produced through the UK’s regulated Specials pathwayAthlone, Ireland — [01 October 2026] — Dunbar Pharmaceuticals (“Dunbar Pharma” or “the Company”), Ireland's...
Dunbar Pharma CEO Leah Fletcher has been featured in a new interview with Manufacturing Chemist, discussing her journey from primary school teacher to founding one of Ireland’s pioneering pharmaceutical companies specialising in plant-derived dronabinol.In the...
Dunbar Pharma Founder and CEO Leah Fletcher discusses the development of pharmaceutical cannabinoid manufacturing in Ireland, the importance of robust pharmaceutical standards, and the evolving landscape for cannabinoid medicines across Europe.Dunbar Pharma Founder...
Irish pharmaceutical manufacturer Dunbar Pharma to discuss API quality following commercial launches in Germany and the UKAthlone, Ireland — [18 August 2026] — Dunbar Pharmaceuticals (“Dunbar Pharma” or “the Company”), Ireland's first EU GMP-certified manufacturer of...
Irish manufacturer brings commercial-scale, EU GMP-certified production and reliable supply to medicines produced through the UK’s regulated Specials pathwayAthlone, Ireland — [18 August 2026] — Dunbar Pharmaceuticals (“Dunbar Pharma” or “the Company”), Ireland's...
Dunbar Pharma’s Leah Fletcher discusses Ireland’s potential in the cannabinoid therapy landscape and how breaking from tradition is a critical step towards advancement.Dunbar Pharma Co-Founder and CEO Leah Fletcher has been featured in Silicon Republic, discussing...
Athlone Based Dunbar Pharma has been named Emerging Company of the Year at the BioPharmaChem Impact Awards 2026, hosted by BioPharmaChem Ireland, Enterprise Ireland and IDA Ireland as part of the annual Impact Conference.
Monksland-based pharmaceutical manufacturer Dunbar Pharma has been named Manufacturing Company of the Year at this year’s Irish Start-Up Awards, in a major national accolade for the Athlone business community.Dunbar Pharma is proud to be awarded Gold in the Product...
Dunbar Pharma is honoured to have been named SME of the Year at the Athlone Chamber of Commerce Business Awards 2025, held at the Hodson Bay Hotel on Saturday 8 November.The award recognises the dedication, innovation and continued growth of our team since Dunbar...